These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 36983942)

  • 1. Evaluating the Immunogenicity and Safety of a Smallpox Vaccine to Monkeypox in Healthy Japanese Adults: A Single-Arm Study.
    Tomita N; Morino E; Terada-Hirashima J; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Ebihara H; Shimojima M; Sugiura W; Ohmagari N; Ujiie M
    Life (Basel); 2023 Mar; 13(3):. PubMed ID: 36983942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpox Neutralizing Antibody Response to LC16m8 Vaccine in Healthy Adults.
    Morino E; Mine S; Tomita N; Uemura Y; Shimizu Y; Saito S; Suzuki T; Okumura N; Iwasaki H; Terada J; Ainai A; Sakai Y; Park E; Seki S; Akazawa D; Shimojima M; Shiwa-Sudo N; Virhuez-Mendoza M; Miyauchi K; Moriyama S; Iwata-Yoshikawa N; Harada M; Harada S; Hishiki T; Kotaki R; Matsumura T; Miyamoto S; Kanno T; Isogawa M; Watashi K; Nagata N; Ebihara H; Takahashi Y; Maeda K; Matano T; Wakita T; Suzuki T; Sugiura W; Ohmagari N; Ujiie M
    NEJM Evid; 2024 Mar; 3(3):EVIDoa2300290. PubMed ID: 38411447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study.
    Yano R; Terada-Hirashima J; Uemura Y; Tomita N; Shimizu Y; Iwasaki H; Okumura N; Suzuki T; Saito S; Ujiie M; Sugiura W; Ohmagari N
    JMIR Res Protoc; 2023 Aug; 12():e46955. PubMed ID: 37624623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox.
    Tomita N; Terada-Hirashima J; Uemura Y; Shimizu Y; Iwasaki H; Yano R; Suzuki T; Saito S; Okumura N; Sugiura W; Ohmagari N; Ujiie M
    Hum Vaccin Immunother; 2023 Aug; 19(2):2242219. PubMed ID: 37559375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status of Vaccine Development for Monkeypox Virus.
    Rastogi A; Kumar M
    Adv Exp Med Biol; 2024; 1451():289-300. PubMed ID: 38801585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic modified vaccinia Ankara vaccines confer cross-reactive and protective immunity against mpox virus.
    Chiuppesi F; Zaia JA; Gutierrez-Franco MA; Ortega-Francisco S; Ly M; Kha M; Kim T; Dempsey S; Kar S; Grifoni A; Sette A; Wussow F; Diamond DJ
    Commun Med (Lond); 2024 Feb; 4(1):19. PubMed ID: 38366141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
    Hubert M; Guivel-Benhassine F; Bruel T; Porrot F; Planas D; Vanhomwegen J; Wiedemann A; Burrel S; Marot S; Palich R; Monsel G; Diombera H; Gallien S; Lopez-Zaragoza JL; Vindrios W; Taieb F; Fernandes-Pellerin S; Delhaye M; Laude H; Arowas L; Ungeheuer MN; Hocqueloux L; Pourcher V; Prazuck T; Marcelin AG; Lelièvre JD; Batéjat C; Lévy Y; Manuguerra JC; Schwartz O
    Cell Host Microbe; 2023 Jun; 31(6):937-948.e4. PubMed ID: 37196656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monkeypox virus in the shadow of the COVID-19 pandemic.
    Khamees A; Awadi S; Al-Shami K; Alkhoun HA; Al-Eitan SF; Alsheikh AM; Saeed A; Al-Zoubi RM; Zoubi MSA
    J Infect Public Health; 2023 Aug; 16(8):1149-1157. PubMed ID: 37269693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview on mRNA-based vaccines to prevent monkeypox infection.
    Natami M; Gorgzadeh A; Gholipour A; Fatemi SN; Firouzeh N; Zokaei M; Mohammed Ali SH; Kheradjoo H; Sedighi S; Gholizadeh O; Kalavi S
    J Nanobiotechnology; 2024 Mar; 22(1):86. PubMed ID: 38429829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Post-Eradication Smallpox Vaccine as an Mpox Vaccine: A Systematic Review with Meta-Analysis.
    Malone SM; Mitra AK; Onumah NA; Brown A; Jones LM; Tresvant D; Brown CS; Onyia AU; Iseguede FO
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36833653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of seroprevalence and kinetics of humoral response using mpox virus A29 protein.
    Cai JP; Chu WM; Tam AR; Wang K; Han Y; Chen LL; Zhang X; Choi CY; Cheng VC; Chan KH; Chen Z; Hung IF; Fong CH; To KK
    Commun Med (Lond); 2023 Nov; 3(1):168. PubMed ID: 37993690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Current State and Progress of Mpox Vaccine Research.
    Wang X; Gu Z; Sheng S; Song R; Jin R
    China CDC Wkly; 2024 Feb; 6(7):118-125. PubMed ID: 38405601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of IMP Dehydrogenase as a Potential Target for Anti-Mpox Virus Agents.
    Hishiki T; Morita T; Akazawa D; Ohashi H; Park ES; Kataoka M; Mifune J; Shionoya K; Tsuchimoto K; Ojima S; Azam AH; Nakajima S; Kawahara M; Yoshikawa T; Shimojima M; Kiga K; Maeda K; Suzuki T; Ebihara H; Takahashi Y; Watashi K
    Microbiol Spectr; 2023 Aug; 11(4):e0056623. PubMed ID: 37409948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The assessment on cross immunity with smallpox virus and antiviral drug sensitivity of the isolated mpox virus strain WIBP-MPXV-001 in China.
    Zeng Y; Liu X; Li Y; Lu J; Wu Q; Dan D; Lv S; Xia F; Hu C; Li J; Zhang H; Du H; Jia R; Duan K; Wang Z; Li X; Yang X
    Emerg Microbes Infect; 2023 Dec; 12(1):2208682. PubMed ID: 37128898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
    Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
    Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Multi-Epitope Universal mRNA Vaccine Candidate for Monkeypox, Smallpox, and Vaccinia Viruses: Design and In Silico Analyses.
    Rcheulishvili N; Mao J; Papukashvili D; Feng S; Liu C; Yang X; Lin J; He Y; Wang PG
    Viruses; 2023 May; 15(5):. PubMed ID: 37243206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in pathogenicity among the mpox virus clades: impact on drug discovery and vaccine development.
    Andrei G; Snoeck R
    Trends Pharmacol Sci; 2023 Oct; 44(10):719-739. PubMed ID: 37673695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox Vaccination.
    Matusali G; Petruccioli E; Cimini E; Colavita F; Bettini A; Tartaglia E; Sbarra S; Meschi S; Lapa D; Francalancia M; Bordi L; Mazzotta V; Coen S; Mizzoni K; Beccacece A; Nicastri E; Pierelli L; Antinori A; Girardi E; Vaia F; Sette A; Grifoni A; Goletti D; Puro V; Maggi F
    Vaccines (Basel); 2023 Sep; 11(10):. PubMed ID: 37896943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and prospects on vaccine development against monkeypox infection.
    Saadh MJ; Ghadimkhani T; Soltani N; Abbassioun A; Daniel Cosme Pecho R; Taha A; Jwad Kazem T; Yasamineh S; Gholizadeh O
    Microb Pathog; 2023 Jul; 180():106156. PubMed ID: 37201635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling the acute phase antibody response against mpox virus in patients infected during the 2022 outbreak.
    Colavita F; Matusali G; Mazzotta V; Bettini A; Lapa D; Meschi S; Francalancia M; Pinnetti C; Bordi L; Mizzoni K; Coen S; Girardi E; Vaia F; Nicastri E; Antinori A; Maggi F
    J Med Virol; 2023 Jun; 95(6):e28851. PubMed ID: 37287343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.